[HTML][HTML] Role of androgen receptor in prostate cancer: a review

K Fujita, N Nonomura - The world journal of men's health, 2019 - synapse.koreamed.org
Androgen receptor (AR) is a steroid receptor transcriptional factor for testosterone and
dihydrotestosterone consisting of four main domains, the N-terminal domain, DNA-binding …

The role of vitamin D in reducing cancer risk and progression

D Feldman, AV Krishnan, S Swami… - Nature reviews …, 2014 - nature.com
Vitamin D is not really a vitamin but the precursor to the potent steroid hormone calcitriol,
which has widespread actions throughout the body. Calcitriol regulates numerous cellular …

[HTML][HTML] Mechanisms of resistance in castration-resistant prostate cancer (CRPC)

T Chandrasekar, JC Yang, AC Gao… - … andrology and urology, 2015 - ncbi.nlm.nih.gov
Despite advances in prostate cancer diagnosis and management, morbidity from prostate
cancer remains high. Approximately 20% of men present with advanced or metastatic …

[HTML][HTML] Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer

L Zhang, Z Lin, Y Chen, D Gao, P Wang, Y Lin… - European journal of …, 2022 - Elsevier
Combination therapy is frequently used in cancer treatments. Delivery of combined
anticancer agents loaded in a nanocarrier would be a promising option for combination …

[HTML][HTML] Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate …

N Wu, YZ Wang, KK Wang, BQ Zhong, YH Liao… - Cell death & …, 2022 - nature.com
A common stage of advanced prostate cancer is castration-resistant prostate cancer
(CRPC), greater understanding of which is required in order to address and solve the …

Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM

S Tian, J Zhang, S Yuan, Q Wang, C Lv… - Briefings in …, 2023 - academic.oup.com
With the emergence of high-throughput technologies, computational screening based on
gene expression profiles has become one of the most effective methods for drug discovery …

Anoikis and EMT: lethal" liaisons" during cancer progression

Z Cao, T Livas, N Kyprianou - Critical Reviews™ in …, 2016 - dl.begellhouse.com
Anoikis is a unique mode of apoptotic cell death that occurs consequentially to insufficient
cell-matrix interactions. Resistance to anoikis is a critical contributor to tumor invasion and …

[HTML][HTML] Treating prostate cancer by antibody–drug conjugates

M Rosellini, M Santoni, V Mollica, A Rizzo… - International journal of …, 2021 - mdpi.com
Prostate cancer is the most frequent malignancy in the worldwide male population; it is also
one of the most common among all the leading cancer-related death causes. In the last two …

Mechanisms of therapeutic resistance in prostate cancer

M Nakazawa, C Paller, N Kyprianou - Current oncology reports, 2017 - Springer
Prostate cancer is the second leading cause of cancer deaths in the USA. The challenge in
managing castration-resistant prostate cancer (CRPC) stems not from the lack of therapeutic …

Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections

X Tao, L Yin, L Xu, J Peng - Pharmacological Research, 2018 - Elsevier
Currently, the numbers of patients with cancer, fibrosis, diabetes, chronic kidney disease,
stroke and osteoporosis are increasing fast and fast. It's critical necessary to discovery lead …